Aleksi Lahti
- Toxicology top 5%
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 5
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 3
- Biochemistry top 5%
- Cancer Research top 10%
- NF-κB Signaling Pathways 2
-
- Nitric Oxide and Endothelin Effects 8
- Asthma and respiratory diseases 2
-
- Cytokine Signaling Pathways and Interactions 3
-
- Protein Kinase Regulation and GTPase Signaling 2
- Melanoma and MAPK Pathways 2
- Co-authors
- Hannu KankaanrantaRiku KorhonenEeva MoilanenMari HämäläinenUlla JalonenRiina NieminenMark A. GiembyczRichard G. Knowles
- Cited by
- ToxicologyImmunologyPharmacology
- Journals
- Biochemical Journal (2 papers)Molecular Pharmacology (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- FinlandNetherlandsCanada
In The Last Decade
Aleksi Lahti
16 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Toxicology 59
- Immunology 344
- Pharmacology 121
- Biochemistry 86
- Cancer Research 164
Countries citing papers authored by Aleksi Lahti
This map shows the geographic impact of Aleksi Lahti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksi Lahti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksi Lahti more than expected).
Fields of papers citing papers by Aleksi Lahti
This network shows the impact of papers produced by Aleksi Lahti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksi Lahti. The network helps show where Aleksi Lahti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aleksi Lahti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2017 | 14 | |
| 3 | 2014 | 49 | |
| 4 | Regulation of inducible nitric oxide synthase expression and nitric oxide production by mitogen-activated protein kinase pathways | 2012 | 0 |
| 5 | 2006 | 33 | |
| 6 | 2006 | 41 | |
| 7 | Nitric Oxide Production and Signaling in Inflammationbreakdown → | 2005 | 805 |
| 8 | 2005 | 56 | |
| 9 | 2005 | 25 | |
| 10 | 2005 | 34 | |
| 11 | 2003 | 76 | |
| 12 | 2003 | 41 | |
| 13 | 2002 | 30 | |
| 14 | 2002 | 42 | |
| 15 | 2002 | 155 | |
| 16 | 2001 | 35 | |
| 17 | 2001 | 25 |
About Aleksi Lahti
Aleksi Lahti is a scholar working on Physiology, Immunology and Toxicology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Inflammatory mediators and NSAID effects (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Asthma and respiratory diseases (2 papers), NF-κB Signaling Pathways (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Toxicology (59 citations), Immunology (344 citations) and Pharmacology (121 citations). Aleksi Lahti has collaborated with scholars based in Finland, Netherlands and Canada. Frequent co-authors include Hannu Kankaanranta, Riku Korhonen, Eeva Moilanen, Eeva Moilanen, Mari Hämäläinen, Ulla Jalonen, Riina Nieminen, Mark A. Giembycz, Richard G. Knowles and Peter J. Barnes. Their work appears in journals such as Biochemical Journal, Molecular Pharmacology, European Journal of Pharmacology, Inflammation Research and Frontline Learning Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.